Literature DB >> 19856864

Human umbilical cord blood cells protect against hypothalamic apoptosis and systemic inflammation response during heatstroke in rats.

Won-Shiung Liu1, Chun-Ta Chen, Ning-Hui Foo, Hsuan-Rong Huang, Jhi-Joung Wang, Sheng-Hsien Chen, Te-Jen Chen.   

Abstract

BACKGROUND: Intravenous administration of human umbilical cord blood cells (HUCBC) has been shown to improve heatstroke by reducing arterial hypotension as well as cerebral ischemia and damage in a rat model. To extend these findings, we assessed both hypothalamic neuronal apoptosis and systemic inflammatory responses in the presence of HUCBCs or vehicle medium immediately after initiation of heatstroke.
METHODS: Anesthetized rats, immediately after the initiation of heat stress, were divided into two groups and given either serum-free lymphocyte medium (0.3mL per rat, intravenously) or HUCBCs (5 x 10(6) in 0.3 mL serum-free lymphocyte medium, intravenously). Another group of rats were exposed to room temperature (26 degrees C) and used as normothermic controls. Heatstroke was induced by exposing the anesthetized rats to a high ambient temperature of 43 degrees C for 68 minutes.
RESULTS: After the onset of heatstroke, animals treated with serum-free lymphocyte medium displayed hyperthermia, hypotension, bradycardia, hypothalamic neuronal apoptosis and degeneration, and up-regulation of systemic inflammatory response molecules including serum tumor necrosis factor-alpha, soluble intercellular adhesion molecule-1 and E-selectin. Heatstroke-induced hypotension, bradycardia, hypothalamic neuronal apoptosis and degeneration, and increased systemic inflammatory response molecules were significantly inhibited by HUCBC treatment. Although heatstroke-induced hyperthermia was not affected by HUCBC treatment, the serum levels of the anti-inflammatory cytokine interleukin-10 were significantly increased by HUCBC therapy during hyperthermia.
CONCLUSIONS: These findings suggest that HUCBC transplantation may prevent the occurrence of heatstroke by reducing hypothalamic neuronal damage and the systemic inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19856864     DOI: 10.1016/S1875-9572(09)60065-6

Source DB:  PubMed          Journal:  Pediatr Neonatol        ISSN: 1875-9572            Impact factor:   2.083


  16 in total

1.  Kynurenic acid attenuates multiorgan dysfunction in rats after heatstroke.

Authors:  Yi-chang Hsieh; Ruei-feng Chen; Yi-shian Yeh; Mao-tsun Lin; Jui-hsiang Hsieh; Sheng-hsien Chen
Journal:  Acta Pharmacol Sin       Date:  2011-02       Impact factor: 6.150

2.  Combination treatment of stroke with sub-therapeutic doses of Simvastatin and human umbilical cord blood cells enhances vascular remodeling and improves functional outcome.

Authors:  X Cui; M Chopp; A Zacharek; J Dai; C Zhang; T Yan; R Ning; C Roberts; A Shehadah; N Kuzmin-Nichols; C D Sanberg; J Chen
Journal:  Neuroscience       Date:  2012-10-04       Impact factor: 3.590

3.  JAK2/STAT3 pathway mediating inflammatory responses in heatstroke-induced rats.

Authors:  Zhen Tao; Ming Cheng; Shu-Cai Wang; Wei Lv; Huai-Qiang Hu; Chuan-Fen Li; Bing-Zhen Cao
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

4.  Transplantation of placenta-derived mesenchymal stem cells reduces hypoxic-ischemic brain damage in rats by ameliorating the inflammatory response.

Authors:  Hongfang Ding; Hui Zhang; Huifang Ding; Dong Li; Xinhao Yi; Xiaoxu Ma; Ruijuan Li; Mei Huang; Xiuli Ju
Journal:  Cell Mol Immunol       Date:  2015-12-28       Impact factor: 11.530

Review 5.  Classic and exertional heatstroke.

Authors:  Abderrezak Bouchama; Bisher Abuyassin; Cynthia Lehe; Orlando Laitano; Ollie Jay; Francis G O'Connor; Lisa R Leon
Journal:  Nat Rev Dis Primers       Date:  2022-02-03       Impact factor: 52.329

6.  Ischemic and oxidative damage to the hypothalamus may be responsible for heat stroke.

Authors:  Sheng-Hsien Chen; Mao-Tsun Lin; Ching-Ping Chang
Journal:  Curr Neuropharmacol       Date:  2013-03       Impact factor: 7.363

7.  Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions.

Authors:  Wan-Zhang Yang; Yun Zhang; Fang Wu; Wei-Ping Min; Boris Minev; Min Zhang; Xiao-Ling Luo; Famela Ramos; Thomas E Ichim; Neil H Riordan; Xiang Hu
Journal:  J Transl Med       Date:  2010-08-03       Impact factor: 5.531

8.  Human umbilical cord blood-derived mononuclear cells improve murine ventricular function upon intramyocardial delivery in right ventricular chronic pressure overload.

Authors:  Saji Oommen; Satsuki Yamada; Susana Cantero Peral; Katherine A Campbell; Elizabeth S Bruinsma; Andre Terzic; Timothy J Nelson
Journal:  Stem Cell Res Ther       Date:  2015-03-26       Impact factor: 6.832

9.  Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomized, placebo-controlled trial.

Authors:  Kyunghoon Min; Junyoung Song; Jin Young Kang; Jooyeon Ko; Ju Seok Ryu; Myung Seo Kang; Su Jin Jang; Sang Heum Kim; Doyeun Oh; Moon Kyu Kim; Sung Soo Kim; Minyoung Kim
Journal:  Stem Cells       Date:  2013-03       Impact factor: 6.277

10.  Honokiol Protected against Heatstroke-Induced Oxidative Stress and Inflammation in Diabetic Rats.

Authors:  Chuan-Chih Hsu; Li-Fan Chen; Mao-Tsun Lin; Yu-Feng Tian
Journal:  Int J Endocrinol       Date:  2014-02-17       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.